|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1505 PRINCE STREET, #300 |
Address2 | |
City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 2981-12
|
||||||||
|
6. House ID# 310990000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jon F. Hymes, Washington Office Director |
Date | 07/19/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ADV
16. Specific lobbying issues
HR 451, Healthcare Truth and Transparency Act of 2011, all sections relating to vision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
|
Michael R |
Duenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 531, Access to Frontline Health Care Act of 2011, all sections relating to vision.
HR 1195, National Health Service Corps Improvement Act of 2011, all sections relating to vision.
S 2192, National Health Service Corps Improvement Act of 2011, all sections relating to vision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Michael R |
Duenas |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 353, Glaucoma Screening Act of 2011, all sections.
HR 364, Common Sense Health Reform Americans Actually Want Act, all sections.
HR 451, Healthcare Truth and Transparency Act of 2011, all sections.
HR 452, Medicare Decisions Accountability Act of 2011, all sections relating to vision.
HR 531, Access to Frontline Health Care Act of 2011, all sections relating to vision.
HR 605, Patients Freedom to Choose Act, all sections relating to vision.
HR 969, Medical Practice Freedom Act of 2011, all sections relating to vision.
HR 1195, National Health Service Corps Improvement Act of 2011, all sections relating to vision
HR 1206, Access to Professional Health Insurance Advisors Act of 2011, all sections relating to vision.
HR 1219, Optometric Equity in Medicaid Act, all sections relating to vision.
HR 3183, To amend title XXVII of the Public Health Service Act to exempt licensed independent insurance producer remuneration from the medical loss ratio, all sections relating to vision.
HR 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all sections relating to vision.
HR 3216, VHA Ophthalmologic Service Establishment Act of 2011, all sections relating to vision.
H.R.3988, Generic Drug and Biosimilar User Fee Act of 2012, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
HR 5651, Food and Drug Administration Reform Act of 2012, All Sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 312, Patients Freedom to Choose Act, all sections relating to vision.
S 2068, Access to Independent Health Insurance Advisors Act of 2012, all sections relating to vision.
S 2192, National Health Service Corps Improvement Act of 2012, , all sections relating to vision.
S 2297, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision.
S 2516, Food and Drug Administration Safety and Innovation Act. All Sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 3187, Food and Drug Administration Safety and Innovation Act, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Michael R |
Duenas |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 452, To repeal the provisions of the Patient Protection and Affordable Care Act providing for the Independent Payment Advisory Board, all sections relating to vision.
HR 1219, Optometric Equity in Medicaid Act, all sections relating to vision.
HR 1256, Medicare Physician Payment Transparency and Assessment Act of 2011, all sections relating to vision.
HR 5707, Medicare Physician Payment Innovation Act of 2012, all sections relating to vision.
S 668, Health Care Bureaucrats Elimination Act, all sections relating to vision.
S 2118, Health Care Bureaucrats Elimination Act, all sections relating to vision.
S 3337, Access to Physicians in Medicare Act of 2012, all sections relating to vision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Michael R |
Duenas |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
HR 791, To amend title 37, United States Code, to provide flexible spending arrangements for members of the uniformed services, and for other purposes, all sections relating to vision.
HR 3216, VHA Ophthalmologic Service Establishment Act of 2011, all sections relating to vision.
HR 3687, To amend title 38, United States Code, to provide for coverage under the beneficiary travel program of the Department of Veterans Affairs of certain disabled veterans for travel for certain special disabilities rehabilitation, and for other purposes, all sections relating to vision.
S 387, To amend title 37, United States Code, to provide flexible spending arrangements for members of the uniformed services, and for other purposes, all provisions related to healthcare, health professionals and certain small business provisions.
S 666, Veterans Traumatic Brain Injury Care Improvement Act of 2011, all sections relating to vision.
S 957, Veterans' Traumatic Brain Injury Rehabilitative Services' Improvements Act of 2011, all sections relating to vision.
S 1124, Veterans Telemedicine Act of 2011, all sections relating to vision.
S 1755, A bill to amend title 38, United States Code, to provide for coverage under the beneficiary travel program of the Department of Veterans Affairs of certain disabled veterans for travel for certain special disabilities rehabilitation, and for other purposes, all sections relating to vision.
S 1867, National Defense Authorization Act, Division A, Title VI, all sections relating to vision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Michael R |
Duenas |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 969, Medical Practice Freedom Act of 2011, all sections relating to vision.
HR 1206 , Access to Professional Health Insurance Advisors Act of 2011, all sections relating to vision.
HR 3183 To amend title XXVII of the Public Health Service Act to exempt licensed independent insurance producer remuneration from the medical loss ratio, all sections relating to vision.
S 2068 Access to Independent Health Insurance Advisors Act of 2012, all sections relating to vision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Michael R |
Duenas |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
HR 451, Healthcare Truth and Transparency Act of 2011, all sections relating to vision.
HR 605, Patients Freedom to Choose Act, all sections relating to vision.
HR 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all sections relating to vision.
HR 3988, Generic Drug and Biosimilar User Fee Act of 2012, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
HR 5651, Food and Drug Administration Reform Act of 2012, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 312, Patients Freedom to Choose Act, all sections relating to vision.
S 2297, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision.
S 2516, Food and Drug Administration Safety and Innovation Act. All Sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 3187, Food and Drug Administration Safety and Innovation Act, All Sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
|
Michael R |
Duenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
HR 1540, National Defense Authorization Act, FY 2012, all sections relating to vision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
|
Michael R |
Duenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
HR 3988, Generic Drug and Biosimilar User Fee Act of 2012, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
HR 5651, Food and Drug Administration Reform Act of 2012, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 2297, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision.
S 2516, Food and Drug Administration Safety and Innovation Act, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 3187, Food and Drug Administration Safety and Innovation Act, all sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
|
Michael R |
Duenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 3988, Generic Drug and Biosimilar User Fee Act of 2012, all sections relating to vision.
HR 5651, To suspend temporarily the rate of duty on 1-Hydroxy cyclohexyl phenyl ketone.
S 2297, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision.
S 2516, Food and Drug Administration Safety and Innovation Act. All Sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
S 3187, Food and Drug Administration Safety and Innovation Act, All Sections related to the practice of optometry including, but not limited to, the reclassification of controlled substances (i.e. hydrocodone).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jon |
Hymes |
|
|
|
David S |
Danielson |
|
|
|
Alicia Kerry |
Jones |
|
|
|
Julie L |
Trute |
|
|
|
Lauren |
Finkelstein |
|
|
|
Matt |
Willette |
|
|
|
Rodney |
Peele |
|
|
|
Michael R |
Duenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |